VanEck Genomics and Healthcare Innovators UCITS ETF (CURG.L)
LSE - LSE Delayed price. Currency in GBP
Add to watchlist
At close: 12:31PM BST
Overall portfolio composition (%)
Stocks99.98%
Bonds0.00%
Sector weightings (%)
Sector(s)CURG.L
Basic materials0.00%
Consumer cyclical0.00%
Financial services0.00%
Property0.00%
Consumer defensive0.00%
Healthcare100.00%
Utilities0.00%
Communication services0.00%
Energy0.00%
Industrials0.00%
Technology0.00%
Equity holdings
AverageCURG.L
Price/Earnings0.03
Price/book0.28
Price/sales0.18
Price/Cash flow0.05
Median market capN/A
3-year earnings growthN/A
Bond ratings
Sector(s)CURG.L
US government0.00%
AAAN/A
AAN/A
AN/A
BBBN/A
BBN/A
BN/A
Below BN/A
OthersN/A
Top 10 holdings (60.30% of total assets)
Get quotes for top holdings| Name | Symbol | % assets |
|---|---|---|
| Moderna Inc | MRNA | 9.78% |
| Vertex Pharmaceuticals Inc | VRTX | 9.16% |
| Regeneron Pharmaceuticals Inc | REGN | 8.34% |
| DexCom Inc | DXCM | 6.44% |
| Veeva Systems Inc Class A | VEEV | 4.82% |
| Natera Inc | NTRA | 4.82% |
| Sarepta Therapeutics Inc | SRPT | 4.51% |
| BioNTech SE ADR | BNTX | 4.42% |
| Illumina Inc | ILMN | 4.39% |
| Qiagen NV | QGEN | 3.63% |
© 2024 Yahoo. All rights reserved.